Big Brown will handle warehousing and transportation globally, on a non-exclusive basis
In late 2009, UPS and Merck shook up the pharma logistics business by forging an unusually close business relationship: UPS would take over two of Merck’s North American distribution centers (DCs)—including hiring their staffs—and be responsible for order fulfillment and transportation for the entire region. Now, the two companies have expanded that relationship globally to include “aspects of Merck’s global supply chain around the world . . . UPS will now provide these services in certain markets in Asia and Latin America, including the emerging markets of China and Brazil. UPS also is providing transportation services in Europe,” according to a UPS statement.
Earlier this year, UPS Healthcare Logistics announced an expansion of its worldwide network of DCs, bringing the total to over 4 million sq. ft.; with the Merck agreement, according to Bill Hook, UPS VP, “We will be able to accelerate this expansion, and shorten the timeline of our five-year strategic plan.” UPS services include temperature-controlled distribution, some repackaging and order-to-cash processes. Hook says that the company is in negotiations with several other multinationals to provide comprehensive, collaborative supply-chain services, but “Merck is at the leading edge of this type of partnership.”
"This expanded agreement with UPS allows us to focus on our core business as a global healthcare leader that looks for innovative ways to bring our medicines and vaccines to patients in emerging markets and markets around the world," said Willie A. Deese, executive vice president and president, Merck Manufacturing Division.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.